Literature DB >> 36266329

Efficient achievement of enteral autonomy facilitates resolution of liver injury in necrotizing enterocolitis induced short bowel syndrome.

Annika Mutanen1, Ville Pöntinen2, Riikka Gunnar3, Laura Merras-Salmio3, Mikko P Pakarinen2.   

Abstract

Children with short bowel syndrome (SBS) are at high risk for intestinal failure associated liver disease (IFALD). The aim of this retrospective follow-up study was to compare weaning off parenteral nutrition (PN) and IFALD between necrotizing enterocolitis (NEC) and non-NEC induced SBS. Altogether, 77 patients with neonatal SBS treated by our multidisciplinary intestinal failure unit (NEC n = 38, non-NEC SBS n = 39) were included and followed-up at least for 2 years until median age of 10 years (interquartile range, 6.0-16). Occurrence and characteristics of IFALD was assessed with liver biopsies obtained at median age of 3.2 (1.0-6.7) years (n = 62) and serum liver biochemistry. Overall, NEC patients had less end-jejunostomies and autologous intestinal reconstruction surgeries performed compared to non-NEC patients (< 0.05), while remaining small bowel anatomy was comparable between groups. Cumulative weaning off PN was more frequent and duration of PN shorter among NEC patients (P < 0.05). Overall cumulative probability of histological IFALD was lower among NEC patients during whole follow-up period (P = 0.052) and at 10 years (P = 0.024). NEC patients had lower ALT and GGT levels at last follow-up (P < 0.05 for all). In univariate Cox regression analysis, absence of end-jejunostomy, NEC diagnosis, longer remaining small bowel length, multidisciplinary treatment and prematurity were predictive for weaning off PN, while NEC diagnosis and lower birth weight in addition to multidisciplinary care protected from histological IFALD. Neonates with NEC induced SBS reached enteral autonomy earlier than those with non-NEC SBS, which associated with more efficient resolution of histological IFALD among long-term survivors.
© 2022. The Author(s).

Entities:  

Mesh:

Year:  2022        PMID: 36266329      PMCID: PMC9584958          DOI: 10.1038/s41598-022-22414-7

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.996


  30 in total

1.  Serum FGF21 increases with hepatic fat accumulation in pediatric onset intestinal failure.

Authors:  Annika Mutanen; Päivi Heikkilä; Jouko Lohi; Taneli Raivio; Hannu Jalanko; Mikko P Pakarinen
Journal:  J Hepatol       Date:  2013-09-07       Impact factor: 25.083

Review 2.  Current Research on the Epidemiology, Pathogenesis, and Management of Necrotizing Enterocolitis.

Authors:  Simon Eaton; Clare M Rees; Nigel J Hall
Journal:  Neonatology       Date:  2017-05-25       Impact factor: 4.035

Review 3.  Cholestasis in the Premature Infant.

Authors:  Carol Jean Potter
Journal:  Clin Perinatol       Date:  2020-03-04       Impact factor: 3.430

4.  Risk factors for parenteral nutrition–associated liver disease following surgical therapy for necrotizing enterocolitis: A Glaser Pediatric Research Network Study [corrected].

Authors:  Debora Duro; Paul D Mitchell; Leslie A Kalish; Cami Martin; Maggie McCarthy; Tom Jaksic; James Dunn; Mary L Brandt; Kerilyn K Nobuhara; Karl G Sylvester; R Lawrence Moss; Christopher Duggan
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-05       Impact factor: 2.839

5.  Enteral autonomy in pediatric short bowel syndrome: predictive factors one year after diagnosis.

Authors:  Farokh R Demehri; Lauren Stephens; Emma Herrman; Brady West; Ann Mehringer; Meghan A Arnold; Pamela I Brown; Daniel H Teitelbaum
Journal:  J Pediatr Surg       Date:  2014-10-26       Impact factor: 2.545

6.  Long-term assessment of bilirubin and transaminase trends in pediatric intestinal failure patients during the era of hepatoprotective parenteral nutrition.

Authors:  Gregory Keefe; Katherine Culbreath; Jamie Knell; Priyanka V Chugh; Steven J Staffa; Tom Jaksic; Biren P Modi
Journal:  J Pediatr Surg       Date:  2021-09-20       Impact factor: 2.545

Review 7.  Exploring the long-term risk factors associated with intestinal failure-associated liver disease in pediatric and adult patients: The role of lipid injectable emulsions in the development of liver disease.

Authors:  Marvick Melendez; Daniel Dante Yeh
Journal:  Nutr Clin Pract       Date:  2022-02-11       Impact factor: 3.204

8.  A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

Authors:  Chun-Tao Wai; Joel K Greenson; Robert J Fontana; John D Kalbfleisch; Jorge A Marrero; Hari S Conjeevaram; Anna S-F Lok
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425

9.  The colon influences ileal resection diarrhea.

Authors:  J E Mitchell; R I Breuer; L Zuckerman; J Berlin; R Schilli; J K Dunn
Journal:  Dig Dis Sci       Date:  1980-01       Impact factor: 3.199

10.  Prediction, identification and progression of histopathological liver disease activity in children with intestinal failure.

Authors:  Annika Mutanen; Jouko Lohi; Laura Merras-Salmio; Antti Koivusalo; Mikko P Pakarinen
Journal:  J Hepatol       Date:  2020-09-28       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.